Richard Lewis Communications

Richard Lewis Communications (RLC) is a specialized public relations and strategic communications firm focused on the healthcare, biotechnology, and pharmaceutical sectors. Founded in 1989 and headquartered in New York, the agency provides expert services in media relations, investor relations, and corporate positioning for life science companies. RLC is recognized for its ability to communicate complex scientific and clinical milestones to investors, physicians, and the general public. In January 2022, the firm was acquired by Gregory FCA, one of the nation's largest independent public relations firms, to bolster its healthcare and life sciences practice. The agency supports a wide range of clients, from emerging biotech startups to established global pharmaceutical leaders, helping them navigate the unique challenges of the healthcare industry.